Siemens Healthineers Shares Slump After Tariffs Hit Profit
By Aimee Look
Siemens Healthineers shares slid after the company's fourth-quarter profit took a hit from higher tariffs.
Shares in the German healthcare company were down 8.7% at 44.99 euros a share in early morning European trading.
On Wednesday, Siemens Healthineers posted a net profit of 597 million euros ($685.5 million) for the three months through Sept. 30, down from 624 million euros in the same period last year.
It reported revenue of 6.32 billion euros for the quarter, down from 6.33 billion euros, but up 3.7% on a comparable basis as the benefits of the streamlining of its diagnostics business took effect.
Analysts had expected a net profit of 659 million euros and revenue of 6.45 billion euros, according to estimates compiled by Vara Research.
Adjusted earnings before interest and taxes fell 2% to 1.09 billion euros. The metric's margin declined to 17.4% from 17.7%.
"Higher tariffs had a negative effect in all segments," the company said, but noted that revenue development and cost reductions from the company's diagnostics business plan were a buffer for the losses.
The next fiscal year is likely to be a transitional year, marking the basis of a new multi-year plan for the company at its Nov. 17 capital markets day, analysts at Jefferies said in a note. Demand for its imaging department will compound continued share gains, they wrote.
Meanwhile, the potential of its parent company Siemens stake reduction in the company or spin-off options will be of interest to investors, analysts at HSBC say in a note.
Write to Aimee Look at aimee.look@wsj.com
(END) Dow Jones Newswires
November 05, 2025 05:12 ET (10:12 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Companies to Invest in Now
The 10 Best Dividend Stocks
